EndoTool®is a highly sophisticated software system that calculates the dose
of IV insulin needed to quickly control blood glucose levels in acute, OR
and critical care settings. This proprietary, FDA-cleared software not only
calculates the dose of IV insulin needed, it actively models and adapts to
individual patient responses to IV insulin — even those with fluctuating
insulin requirements. EndoTool®
integrates more than 30 unique algorithms, and its sophisticated control
mathematics ensure an extremely low incidence of hypoglycemia, <0.05% of
readings.
EndoTool® was developed
by Interplat for MD Scientific, LLC, a medical products company based in
Charlotte, NC. EndoTool®
was purchased from MD Scientific in late 2008 by Hospira, Inc., a global
specialty pharmaceutical and medication delivery company with over $3
billion in sales.
More...
Echo
Interplat Solutions
is currently developing Echo for Business Health Solutions.
More...
Contact Information:
